Phio Pharmaceuticals Corp. (PHIO)
1.035
+0.02
(+2.48%)
USD |
NASDAQ |
Sep 11, 14:41
Phio Pharmaceuticals Gross Profit (TTM) : -0.005M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.005M |
| March 31, 2026 | -0.004M |
| December 31, 2025 | -0.003M |
| September 30, 2025 | -0.002M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | -0.001M |
| December 31, 2024 | -0.035M |
| September 30, 2024 | -0.078M |
| June 30, 2024 | -0.125M |
| March 31, 2024 | -0.171M |
| December 31, 2023 | -0.184M |
| September 30, 2023 | -0.187M |
| June 30, 2023 | -0.186M |
| March 31, 2023 | -0.188M |
| December 31, 2022 | -0.193M |
| September 30, 2022 | -0.197M |
| June 30, 2022 | -0.199M |
| March 31, 2022 | -0.197M |
| December 31, 2021 | -0.192M |
| September 30, 2021 | -0.187M |
| June 30, 2021 | -0.185M |
| March 31, 2021 | -0.185M |
| December 31, 2020 | -0.183M |
| September 30, 2020 | -0.154M |
| June 30, 2020 | -0.123M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.094M |
| December 31, 2019 | -0.049M |
| September 30, 2019 | -0.053M |
| June 30, 2019 | -0.038M |
| March 31, 2019 | -0.02M |
| December 31, 2018 | -0.02M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.021M |
| March 31, 2018 | -0.037M |
| December 31, 2017 | -0.048M |
| September 30, 2017 | -0.06M |
| June 30, 2017 | -0.052M |
| March 31, 2017 | -0.036M |
| December 31, 2016 | -0.025M |
| September 30, 2016 | -0.03M |
| June 30, 2016 | -0.036M |
| March 31, 2016 | -0.056M |
| December 31, 2015 | -0.056M |
| September 30, 2015 | -0.039M |
| June 30, 2015 | -0.02M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Imunon, Inc. | -0.6718M |
| Agenus, Inc. | 127.32M |
| Amgen, Inc. | 27.78B |
| Anika Therapeutics, Inc. | 75.00M |
| BioCryst Pharmaceuticals, Inc. | 917.38M |